SCHEMBL6947706

SCHEMBL6947706

CC(C)(C)OC(=O)ON1CCC(c2ccc(F)cc2)C(O)C1

nearest known ligand 0.41

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
ENPP2 Q13822 1/20 0.38
SLC6A3 Q01959 4/20 0.37
SLC6A4 P31645 2/20 0.37
TACR1 P25103 2/20 0.36
KDM1A O60341 1/20 0.36
RORC P51449 3/20 0.35
NPC1 O15118 1/20 0.34
MAPT P10636 1/20 0.34
RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4602631 0.89 MEN1 (0.39) MEN1KMT2ASLC6A3SLC6A4KDM1A
SCHEMBL6949144 0.89 GPR119 (0.39) MEN1KMT2AKDM1ANPC1RAB9A
SCHEMBL5562101 0.89 MEN1 (0.39) MEN1KMT2ASLC6A3SLC6A4KDM1A
SCHEMBL6958285 0.88
SCHEMBL6954303 0.88 MEN1 (0.38) MEN1KMT2ASLC6A3SLC6A4KDM1A
SCHEMBL6950872 0.88 HTT (0.45) MEN1KMT2ASLC6A3SLC6A4TACR1
SCHEMBL6950896 0.86 RIPK1 (0.45) TACR1
SCHEMBL6951206 0.86 MEN1 (0.39) MEN1KMT2ATACR1KDM1ARORC
SCHEMBL6953026 0.85 TACR1 (0.35) MEN1KMT2ASLC6A3SLC6A4TACR1
SCHEMBL6961545 0.85 TACR1 (0.40) MEN1KMT2ATACR1KDM1ARORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0863875-B1 NEW 4-(OXYALKOXYPHENYL)-3-OXY-PIPERIDINES FOR TREATING HEART AND KIDNEY INSUFFICIENCY HOFFMANN LA ROCHE (CH) 2003-06-04 EP disclosed
EP-0863875-A1 NEW 4-(OXYALKOXYPHENYL)-3-OXY-PIPERIDINES FOR TREATING HEART AND KIDNEY INSUFFICIENCY F. HOFFMANN-LA ROCHE AG (CH) 1998-09-16 EP disclosed
WO-1997009311-A1 NEW 4-(OXYALKOXYPHENYL)-3-OXY-PIPERIDINES FOR TREATING HEART AND KIDNEY INSUFFICIENCY F. HOFFMANN-LA ROCHE AG (CH) 1997-03-13 WO disclosed